![Richmar DQ8222 Operation Manual Download Page 15](http://html1.mh-extra.com/html/richmar/dq8222/dq8222_operation-manual_1454541015.webp)
TheraTouch® CX2/CX4/EX4
11
RAAS (Biphasic)
Rapid Agonist Antagonist Sequencing
(RAAS) is proposed to mimic muscle-firing
patterns of healthy individuals. It uses
the electrical stimulation of sensory and
motor nerves to achieve a skeletal muscle
contraction using an electromyogram
— derived functional pattern. It is used
extensively for neuromuscular reeducation
and treatment of muscle disuse atrophy.
WAVEFORM SPECIFICATIONS
PARAMETERS
Phase
Duration
Expressed in
μ
s, is the
time it takes to complete
one phase of a pulse. The
length affects the type of
nerve recruited.
Frequency
In a pulsed current, the
Frequency refers to the
number of pulses that
occur in a one second
period of time and is
denoted in (Hz) or Pulses
Per Second (pps).
Burst
Duration
The time elapsed from
the beginning to the
end of one burst, and is
denoted in (ms)
Pattern
Frequency
The Pattern Frequency
refers to the number of
the sequential pulse train
pattern be repeated in
a one second period of
time and is denoted in
(Hz).
STIMULATOR OUTPUT PARAMETERS
RAAS Biphasic
Output Mode Electrodes
Mode
selection
CC (Constant Current) or
CV (Constant voltage)
Intensity
CC: 0 – 200mA, Stepping
0.5mA;
CV: 0 – 200V, Stepping
0.5V
Phase
Duration
20
μ
s – 1,000
μ
s, Stepping
5
μ
s
Frequency
1 – 250 Hz, Stepping 1 Hz
Burst
Duration
100ms – 5,000ms,
Stepping Adaptive
Pattern
Frequency
0.7 Hz (Burst Duration
100ms-500ms)
0.3 Hz (Burst Duration
500ms-1,000ms)
0.15 Hz (Burst Duration
1,000ms-2,000ms)
0.07 Hz (Burst Duration
2,000ms-5,000ms)
Treatment
Time
1 – 60 Minutes
Burst Duration
Phase Duration
Ch 1
Ch 2